Stromal fibrosis and ovarian aging depend not only on the age of the patients but also on environmental factors, lifestyle and physiological events such as ovulation itself, which leaves repeated scarring in the ovarian stroma, limiting normal tissue vascularization and the provision of biological signals necessary to maintain folliculogenesis and hormone synthesis. In a fibrosed ovarian stroma, there is a decrease in hyaluronic acid concentrations, loss of synthesis and migration proteins, a decrease in microRNAs, in addition to enzymatic alterations that affect mitochondrial kinases, increasing oxygen free radicals, which accelerate cell death. This study seeks to analyze the effectiveness of autologous exosomes in reversing aging and bioregenerating the ovary of patients with ovarian failure and infertility by improving interstitial fibrosis and providing the necessary elements to activate neofolliculogenesis. Prospective, randomized, comparative study in 30 women between 38 and 46 years old, with diminished ovarian reserve and who rejected the egg donation procedure. Three study groups composed of 10 patients each: the first with autologous exosomes, the second with PRP and the third with saline solution. After completing the study, it was found that women in the Autologous Exosome group showed better ovarian reserve parameters such as FSH, LH, Estradiol, Anti-Müllerian Hormone and antral follicle count, edema of more oocytes collected in Metaphase II, higher fertilization rate, frozen embryos and positive pregnancies. Ovarian Biostimulation with Autologous Exosomes could be considered a safe and promising therapy to improve markers of low ovarian reserve. Clinical Trials.gov. Registration Number: NCT06773572. URL: Study Details | Use of Autologous Exosomes vs Platelet Growth Factors to Regenerate the Ovary in Women With Infertility (Exosomas2024-1) | ClinicalTrials.gov.
Oocyte development begins during embryonic life and remains arrested in prophase I until meiotic resumption during ovulation. A substantial proportion of oocytes retrieved during assisted reproductive procedures remain immature at the metaphase I (MI) stage and fail to achieve the maturation required for fertilization. In women with diminished ovarian reserve, alterations in the ovarian microenvironment may impair the biochemical signaling necessary for normal oocyte development. Autologous exosomes have emerged as a potential strategy to enhance meiotic progression through the transfer of bioactive molecules. This study aimed to evaluate the in vitro efficacy of autologous exosomes in improving the maturation potential of immature oocytes in women with diminished ovarian reserve. A prospective, randomized, controlled pilot study was conducted in 32 women aged 38–46 years. A total of 111 oocytes were retrieved (52 metaphase II [MII] and 59 MI oocytes), and only MI oocytes were included in the experimental analysis. MI oocytes were cultured either in conventional medium or in medium supplemented with autologous exosomes. The exosome-supplemented group demonstrated significantly higher in vitro maturation rates compared with the conventional culture group (63.63% vs. 11.53%; p < 0.001). Fertilization rates among matured oocytes were 76.19% and 33.33% in Groups II and I, respectively. In addition, favorable embryo development outcomes were observed in the exosome-treated group. Autologous exosome supplementation may enhance in vitro maturation and fertilization outcomes in women with diminished ovarian reserve. After accounting for clustering of oocytes within patients using generalized estimating equations, exosome supplementation remained significantly associated with successful oocyte maturation (OR 15.46, 95% CI 5.16–46.39; p < 0.001).
27 August 2026 in Revista de Obstetricia y Ginecología de Venezuela